Tumor-induced osteomalacia (TIO) is a subtype of paraneoplastic syndrome associated with hypophosphatemia due to renal phosphate wasting in adults. The humoral factor responsible for clinical picture known as fibroblast growth factor 23 (FGF23) is most often secreted by benign yet elusive mesenchymal tumors, difficult to localize, access, and excise completely; rarely, they are multiple and mal...

Fibroblast growth factor-23 (FGF-23) is a potent circulating phosphaturic factor associated with renal phosphate wasting. The effects of FGF-23 on skeletal and phosphate homeostasis have been investigated widely; however, the effect of FGF-23 on the cardiovascular system (CVS) is unknown. To assess whether FGF-23 influences the function and structure of the CVS and whether the effect of FGF-23 ...

Objectives: To investigate the prevalence of posttransplant hypophosphatemia in early period among renal transplant recipients relation to its impact on graft function. Methods: A total 78 who were transplanted between January 2016 and March 2020 included this retrospective single center study. Data laboratory findings (phosphate, creatinine, estimated glomerular filtration rate [eGFR], albumin...

SummaryBackground & aims Phosphate is the main intracellular anion essential for numerous biological processes. Symptoms of hypophosphatemia are non-specific, yet potentially life-threatening. This systematic review process was initiated to gain a global insight into hypophosphatemia, associated morbidity and treatments. Methods A conducted (PROSPERO CRD42020163191). ...